Bethesda Hospice Care 1630 Des Peres Rd, Ste 200, Saint Louis, MO, 63131 | |
(314) 446-0623 |
News Archive
The use of digital health technologies across health care and drug development has accelerated. A new paper titled "Digital Progression Biomarkers as Novel Endpoints in Clinical Trials: A Multistakeholder Perspective," co-authored by experts across diverse disciplines, highlights how new remote monitoring technologies present a tremendous opportunity to advance digital medicine in health care even further, specifically in Parkinson's disease.
"The Medicaid expansion under health reform is expected to strain state budgets already distressed by the recession, despite delays for new eligibility rules and federal aid, Moody's Investors Service said in a newly released report. States that see the largest gains in Medicaid enrollment under health reform will likely see the greatest financial burden, Moody's said."
Thermo Fisher Scientific Inc., the world leader in serving science, today announced that its global Food Safety Response Center located in Dreieich, Germany, has developed two new analytical screening methods to detect petroleum contamination in oysters and fish, specifically hydrocarbons and poly-aromatic hydrocarbons (PAHs), resulting from the oil spill in the Gulf of Mexico.
InSightec Ltd, the global leader in MR guided Focused Ultrasound (MRgFUS), announced that it has received approval from the US Food and Drug Administration to begin a Phase I clinical trial evaluating the use of its ExAblate Neuro system for the treatment of patients with tremor dominant Parkinson's Disease.
› Verified 7 days ago
Name | Bethesda Hospice Care |
---|---|
Location | 1630 Des Peres Rd, Ste 200, Saint Louis, Missouri |
Hospice ID | 261591 |
Category | Freestanding Hospice |
Ownership Type | Voluntary Non-profit - Private |
Profit Type | NON-PROFIT |
SSA county code | 940 |
News Archive
The use of digital health technologies across health care and drug development has accelerated. A new paper titled "Digital Progression Biomarkers as Novel Endpoints in Clinical Trials: A Multistakeholder Perspective," co-authored by experts across diverse disciplines, highlights how new remote monitoring technologies present a tremendous opportunity to advance digital medicine in health care even further, specifically in Parkinson's disease.
"The Medicaid expansion under health reform is expected to strain state budgets already distressed by the recession, despite delays for new eligibility rules and federal aid, Moody's Investors Service said in a newly released report. States that see the largest gains in Medicaid enrollment under health reform will likely see the greatest financial burden, Moody's said."
Thermo Fisher Scientific Inc., the world leader in serving science, today announced that its global Food Safety Response Center located in Dreieich, Germany, has developed two new analytical screening methods to detect petroleum contamination in oysters and fish, specifically hydrocarbons and poly-aromatic hydrocarbons (PAHs), resulting from the oil spill in the Gulf of Mexico.
InSightec Ltd, the global leader in MR guided Focused Ultrasound (MRgFUS), announced that it has received approval from the US Food and Drug Administration to begin a Phase I clinical trial evaluating the use of its ExAblate Neuro system for the treatment of patients with tremor dominant Parkinson's Disease.
› Verified 7 days ago
NPI Number | 1437125499 |
Organization Name | Bethesda Services, Inc |
Address | 707 Bethesda Dilworth Dr Saint Louis, Missouri, 63122 |
Phone Number | (314)446-0623 |
News Archive
The use of digital health technologies across health care and drug development has accelerated. A new paper titled "Digital Progression Biomarkers as Novel Endpoints in Clinical Trials: A Multistakeholder Perspective," co-authored by experts across diverse disciplines, highlights how new remote monitoring technologies present a tremendous opportunity to advance digital medicine in health care even further, specifically in Parkinson's disease.
"The Medicaid expansion under health reform is expected to strain state budgets already distressed by the recession, despite delays for new eligibility rules and federal aid, Moody's Investors Service said in a newly released report. States that see the largest gains in Medicaid enrollment under health reform will likely see the greatest financial burden, Moody's said."
Thermo Fisher Scientific Inc., the world leader in serving science, today announced that its global Food Safety Response Center located in Dreieich, Germany, has developed two new analytical screening methods to detect petroleum contamination in oysters and fish, specifically hydrocarbons and poly-aromatic hydrocarbons (PAHs), resulting from the oil spill in the Gulf of Mexico.
InSightec Ltd, the global leader in MR guided Focused Ultrasound (MRgFUS), announced that it has received approval from the US Food and Drug Administration to begin a Phase I clinical trial evaluating the use of its ExAblate Neuro system for the treatment of patients with tremor dominant Parkinson's Disease.
› Verified 7 days ago
NPI Number | 1902066673 |
Organization Name | Bethesda Hospice |
Address | 1630 Des Peres Rd Saint Louis, Missouri, 63131 |
Phone Number | (314)800-1900 |
News Archive
The use of digital health technologies across health care and drug development has accelerated. A new paper titled "Digital Progression Biomarkers as Novel Endpoints in Clinical Trials: A Multistakeholder Perspective," co-authored by experts across diverse disciplines, highlights how new remote monitoring technologies present a tremendous opportunity to advance digital medicine in health care even further, specifically in Parkinson's disease.
"The Medicaid expansion under health reform is expected to strain state budgets already distressed by the recession, despite delays for new eligibility rules and federal aid, Moody's Investors Service said in a newly released report. States that see the largest gains in Medicaid enrollment under health reform will likely see the greatest financial burden, Moody's said."
Thermo Fisher Scientific Inc., the world leader in serving science, today announced that its global Food Safety Response Center located in Dreieich, Germany, has developed two new analytical screening methods to detect petroleum contamination in oysters and fish, specifically hydrocarbons and poly-aromatic hydrocarbons (PAHs), resulting from the oil spill in the Gulf of Mexico.
InSightec Ltd, the global leader in MR guided Focused Ultrasound (MRgFUS), announced that it has received approval from the US Food and Drug Administration to begin a Phase I clinical trial evaluating the use of its ExAblate Neuro system for the treatment of patients with tremor dominant Parkinson's Disease.
› Verified 7 days ago
Quality Measure | Provider Score | National Score |
---|---|---|
Patients or caregivers who were asked about treatment preferences like hospitalization and resuscitation at the beginning of hospice care | 100.0 | 98.3 |
Patients or caregivers who were asked about their beliefs and values at the beginning of hospice care | 100.0 | 93.6 |
Patients who were checked for pain at the beginning of hospice care | 99.4 | 93.9 |
Patients who got a timely and thorough pain assessment when pain was identified as a problem | Not Available | 77.7 |
Patients who were checked for shortness of breath at the beginning of hospice care | 100.0 | 97.3 |
Patients who got timely treatment for shortness of breath | Not Available | 94.6 |
Patients taking opioid pain medication who were offered care for constipation | 100.0 | 93.3 |
News Archive
The use of digital health technologies across health care and drug development has accelerated. A new paper titled "Digital Progression Biomarkers as Novel Endpoints in Clinical Trials: A Multistakeholder Perspective," co-authored by experts across diverse disciplines, highlights how new remote monitoring technologies present a tremendous opportunity to advance digital medicine in health care even further, specifically in Parkinson's disease.
"The Medicaid expansion under health reform is expected to strain state budgets already distressed by the recession, despite delays for new eligibility rules and federal aid, Moody's Investors Service said in a newly released report. States that see the largest gains in Medicaid enrollment under health reform will likely see the greatest financial burden, Moody's said."
Thermo Fisher Scientific Inc., the world leader in serving science, today announced that its global Food Safety Response Center located in Dreieich, Germany, has developed two new analytical screening methods to detect petroleum contamination in oysters and fish, specifically hydrocarbons and poly-aromatic hydrocarbons (PAHs), resulting from the oil spill in the Gulf of Mexico.
InSightec Ltd, the global leader in MR guided Focused Ultrasound (MRgFUS), announced that it has received approval from the US Food and Drug Administration to begin a Phase I clinical trial evaluating the use of its ExAblate Neuro system for the treatment of patients with tremor dominant Parkinson's Disease.
› Verified 7 days ago
Home Health Aides | 4 |
Counselors | 2.5 |
Homemakers | 0.05 |
Licensed Practical or Vocational Nurses | 4 |
Medical Social Workers | 5.5 |
Physicians | 0.1 |
Registered Nurses | 6 |
Total Employees | 22.15 |
---|
News Archive
The use of digital health technologies across health care and drug development has accelerated. A new paper titled "Digital Progression Biomarkers as Novel Endpoints in Clinical Trials: A Multistakeholder Perspective," co-authored by experts across diverse disciplines, highlights how new remote monitoring technologies present a tremendous opportunity to advance digital medicine in health care even further, specifically in Parkinson's disease.
"The Medicaid expansion under health reform is expected to strain state budgets already distressed by the recession, despite delays for new eligibility rules and federal aid, Moody's Investors Service said in a newly released report. States that see the largest gains in Medicaid enrollment under health reform will likely see the greatest financial burden, Moody's said."
Thermo Fisher Scientific Inc., the world leader in serving science, today announced that its global Food Safety Response Center located in Dreieich, Germany, has developed two new analytical screening methods to detect petroleum contamination in oysters and fish, specifically hydrocarbons and poly-aromatic hydrocarbons (PAHs), resulting from the oil spill in the Gulf of Mexico.
InSightec Ltd, the global leader in MR guided Focused Ultrasound (MRgFUS), announced that it has received approval from the US Food and Drug Administration to begin a Phase I clinical trial evaluating the use of its ExAblate Neuro system for the treatment of patients with tremor dominant Parkinson's Disease.
› Verified 7 days ago
Others | 0.5 |
Total Volunteers | 0.5 |
---|
News Archive
The use of digital health technologies across health care and drug development has accelerated. A new paper titled "Digital Progression Biomarkers as Novel Endpoints in Clinical Trials: A Multistakeholder Perspective," co-authored by experts across diverse disciplines, highlights how new remote monitoring technologies present a tremendous opportunity to advance digital medicine in health care even further, specifically in Parkinson's disease.
"The Medicaid expansion under health reform is expected to strain state budgets already distressed by the recession, despite delays for new eligibility rules and federal aid, Moody's Investors Service said in a newly released report. States that see the largest gains in Medicaid enrollment under health reform will likely see the greatest financial burden, Moody's said."
Thermo Fisher Scientific Inc., the world leader in serving science, today announced that its global Food Safety Response Center located in Dreieich, Germany, has developed two new analytical screening methods to detect petroleum contamination in oysters and fish, specifically hydrocarbons and poly-aromatic hydrocarbons (PAHs), resulting from the oil spill in the Gulf of Mexico.
InSightec Ltd, the global leader in MR guided Focused Ultrasound (MRgFUS), announced that it has received approval from the US Food and Drug Administration to begin a Phase I clinical trial evaluating the use of its ExAblate Neuro system for the treatment of patients with tremor dominant Parkinson's Disease.
› Verified 7 days ago
Mercy Hospice Location: 1000 Des Peres, Suite 200b, Saint Louis, Missouri, 63131 Phone: (314) 446-0623 |
Bjc Hospice Location: 1935 Beltway Drive, Saint Louis, Missouri, 63114 Phone: (314) 446-0623 |
Kindred Hospice Location: 2055 Craigshire Road, Suite 410, Saint Louis, Missouri, 63146 Phone: (314) 446-0623 |
Heartland Hospice Services Location: 12101 Woodcrest Executive Drive, Suite 102, Saint Louis, Missouri, 63141 Phone: (314) 446-0623 |